Technical Analysis for CELC - Celcuity Inc.

Grade Last Price % Change Price Change
grade D 20.43 -1.11% -0.23
CELC closed down 1.11 percent on Friday, March 22, 2019, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CELC trend table...

Date Alert Name Type % Chg
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 21 MACD Bullish Signal Line Cross Bullish -1.11%
Mar 21 Multiple of Ten Bullish Other -1.11%
Mar 21 Wide Bands Range Expansion -1.11%
Mar 20 Multiple of Ten Bearish Other 2.77%
Mar 20 Wide Bands Range Expansion 2.77%
Mar 19 Multiple of Ten Bullish Other 1.49%
Mar 19 Wide Bands Range Expansion 1.49%
Mar 18 NR7 Range Contraction 1.14%

Older signals for CELC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Celcuity, Inc. is a United States-based early stage biotechnology company. The Company develops tests that functionally analyze diseased live cells. The Company has developed CELx Pathway Profile technology, which combines advancements in primary tissue research with a method of measuring a targeted therapy's functional pathway effect on live and diseased patient cells. The Company offers functional cellular analysis platform that assesses the functionality of the disease-related signaling pathways of patient's diseased cells ex vivo and determines whether a drug therapy has the effect on diseased cells. The Company's CELx test is designed to determine whether a pathway is functional to therapeutic intervention without regard to the exact mechanism a patient's tumor may have developed to resist the therapeutic effect. The Company’s diagnostic approach helps to identify cancer subtypes.
Biotechnology Cancer Biology Stem Cells Cell Biology Cell Signaling Signal Transduction Drug Therapy Patient's Tumor Systems Biology
Is CELC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.0
52 Week Low 15.275
Average Volume 9,356
200-Day Moving Average 24.261
50-Day Moving Average 21.9046
20-Day Moving Average 20.764
10-Day Moving Average 20.137
Average True Range 1.0753
ADX 18.95
+DI 20.7579
-DI 25.3207
Chandelier Exit (Long, 3 ATRs ) 21.0241
Chandelier Exit (Short, 3 ATRs ) 21.5334
Upper Bollinger Band 23.6821
Lower Bollinger Band 17.8459
Percent B (%b) 0.44
BandWidth 28.107301
MACD Line -0.6011
MACD Signal Line -0.6835
MACD Histogram 0.0824
Fundamentals Value
Market Cap 198.62 Million
Num Shares 9.72 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -1021.50
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.31
Resistance 3 (R3) 21.27 20.93 21.16
Resistance 2 (R2) 20.93 20.71 20.95 21.11
Resistance 1 (R1) 20.68 20.57 20.81 20.72 21.06
Pivot Point 20.35 20.35 20.41 20.37 20.35
Support 1 (S1) 20.10 20.12 20.22 20.14 19.80
Support 2 (S2) 19.76 19.99 19.78 19.75
Support 3 (S3) 19.51 19.76 19.70
Support 4 (S4) 19.55